3.48
-0.005(-0.14%)
Currency In USD
| Previous Close | 3.48 |
| Open | 3.49 |
| Day High | 3.53 |
| Day Low | 3.42 |
| 52-Week High | 6.54 |
| 52-Week Low | 2.03 |
| Volume | 34,017 |
| Average Volume | 118,031 |
| Market Cap | 182.24M |
| PE | -3.62 |
| EPS | -0.96 |
| Moving Average 50 Days | 3.75 |
| Moving Average 200 Days | 3.33 |
| Change | -0.01 |
If you invested $1000 in Sight Sciences, Inc. (SGHT) since IPO date, it would be worth $103.88 as of September 29, 2025 at a share price of $3.48. Whereas If you bought $1000 worth of Sight Sciences, Inc. (SGHT) shares 3 years ago, it would be worth $570.49 as of September 29, 2025 at a share price of $3.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use
GlobeNewswire Inc.
Sep 17, 2025 11:00 AM GMT
The study, published in The European Journal of Ophthalmology, included 29 publications and concluded that favorable long-term safety and efficacy profiles make OMNI a beneficial treatment option for patients with primary open-angle glaucomaMENLO PAR
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
GlobeNewswire Inc.
Sep 09, 2025 11:05 AM GMT
UnitedHealthcare’s Coverage Policy includes procedures enabled with OMNI Surgical System technology, the leader in implant-free MIGS, are proven and medically necessaryMENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nas
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
GlobeNewswire Inc.
Sep 02, 2025 8:05 PM GMT
This report provides an evidence-based review of current treatments for managing dry eye disease (DED) and highlights support for TearCare based on strong clinical dataMENLO PARK, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nas